Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Fenwick & West LLP ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5  
>>Next
 
Title
Country
Organisation
Author
Date
1
SEC Fines Life Sciences Company for Regulation FD Violations
For the first time in six years, the U.S. Securities and Exchange Commission issued an enforcement action against a company solely for Regulation FD violations. On Aug. 20
United States
28 Aug 2019
2
Technology And Life Sciences IPO Survey – 2019, H1
The year 2019 so far has proven to be strong for initial public offerings.
United States
8 Aug 2019
3
Q2 2019: Big Deals In China, Drones And The Return Of The Digital Health IPO
Rock Health reported that $4.2 billion was invested in digital health companies during the first half of 2019.
United States
25 Jul 2019
4
US Health Consumers Demand More: Can Tech Save Us?
In the latest edition of the Internet Trends report, Mary Meeker highlights the growing digitization of the healthcare sector, framing that growth squarely in the context of a U.S.
United States
9 Jul 2019
5
Life Sciences IPOs Haven't Slowed In 2019
In our 2018 year-end review of life sciences and tech IPOs, we noted that life sciences offerings totaled 67 raising an average of $133 million while there were 45 technology deals raising an average
United States
1 Jul 2019
6
Divestitures And Consolidation In Animal Health Market Present Opportunities To Investors, Innovators
The business of animal health has traditionally been dominated by the animal health divisions of big pharma companies.
United States
31 May 2019
7
How AI Is Transforming Healthcare: Diagnostics, R&D And Therapeutics
The impact of artificial intelligence, or more specifically machine learning, is being felt in every industry sector ...
United States
13 Feb 2019
8
Fenwick's Top 10: Our Most Popular Articles Of 2018
Venture financing trends, SEC enforcement actions, U.S. tax law changes and the IPO market dominated our readers' attention in 2018.
United States
15 Jan 2019
9
Silicon Valley Venture Capital Survey – Third Quarter 2018
We analyzed the terms of 215 venture financings closed in the third quarter of 2018 by companies headquartered in Silicon Valley.
United States
14 Nov 2018
10
Advanced Tech, Crossover Investors Drive Biopharmaceutical IPO Surge
​Fenwick securities and corporate finance co-chair Rob Freedman talked to The Wall Street Journal about the life sciences IPO market and what to look for next.
United States
22 Oct 2018
11
Top SCOTUS Cases That Matter For Tech, Life Sciences And Games Industries – 2018 Term Preview
As the U.S. Supreme Court kicks off its 2018 term this week, it prepares to take up a series of firsts, including questions about the America Invents Act, securities fraud and privacy-related class action litigation.
United States
4 Oct 2018
12
Technology And Life Sciences IPO Survey – 2018, H1
Despite significant market volatility at the start of the year, life sciences and technology IPOs around the world came out strong in H1 2018, with no slowdown in sight.
United States
6 Sep 2018
13
Life Sciences And Tech Companies Should Take Note Of These New SEC Amendments
The U.S. Securities and Exchange Commission this month adopted amendments to certain disclosure requirements in an effort to streamline rules and regulations, and to remove requirements that are "redundant, duplicative, overlapping, outdated, or superseded."
United States
2 Sep 2018
14
Shaking Up Terra FIRRMA: Implications Of CFIUS Reform For Tech And Life Sciences Companies
The shadow cast over the technology industry by the Committee on Foreign Investment in the U.S. has been growing in recent years, resulting in the blocking of various high-profile technology deals
United States
29 Aug 2018
15
Digital Health Investment Trends Q2 2018: Megadeals Become The Norm, China Rising
Private investment in digital health continued apace in the second quarter of 2018, based on our latest look at deal flow.
United States
26 Jul 2018
16
Takeaways From The 11th Circuit's Reversal Of The FTC's Data Security Order Against LabMD
The U.S. Court of Appeals for the Eleventh Circuit on June 6 issued its long-awaited decision in LabMD v. FTC, vacating a FTC cease and desist order directing LabMD to overhaul its data security program...
United States
12 Jul 2018
17
Investors Make Big Bets On Diagnostics In Q1 2018
Two trends stood out in our analysis of private digital health investments in the first quarter of 2018: bigger deals and more investment in companies targeting the regulated portion of the health care market.
United States
3 May 2018
18
Technology And Life Sciences IPO Survey – 2017, Full Year
This report analyzes key aspects of initial public offerings (IPOs) for technology and life sciences companies that went public in 2017, with emphasis ...
United States
9 Feb 2018
19
JPM Conference Takeaways: Biotech And Biopharma Set For Growth In 2018
Coming off a year that saw a record number of new drug approvals, significant scientific breakthroughs and a year-end tax reform package that both significantly lowers corporate taxes ...
United States
8 Feb 2018
20
Failure To Quantify U.S. Vs. Worldwide Sales Costs Life Sciences Company A Damages Award
Any patent plaintiff would be thrilled to get a ruling of infringement on summary judgment — but if that win ultimately resulted in zero damages, it would ring hollow.
United States
10 Jan 2018
Links to Result pages
 
1 2 3 4 5  
>>Next